|
ABUS
|
Arbutus Biopharma Corporation
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
US
|
NASDAQ
|
|
AIM
|
AIM ImmunoTech Inc.
|
US
|
AMEX
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
US
|
NASDAQ
|
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CANF
|
Can-Fite Biopharma Ltd Sponsored ADR (Israel)
|
US
|
AMEX
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
DCTH
|
Delcath Systems, Inc.
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
US
|
NASDAQ
|
|
NYMX
|
Nymox Pharmaceutical Corporation
|
US
|
NASDAQ
|
|
ONCS
|
OncoSec Medical Incorporated
|
US
|
NASDAQ
|
|
PBLA
|
Panbela Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PIRS
|
Pieris Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
RGLS
|
Regulus Therapeutics Inc.
|
US
|
NASDAQ
|
|
SESN
|
Sesen Bio, Inc.
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
US
|
NASDAQ
|
|
TCON
|
TRACON Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
TCRR
|
TCR2 Therapeutics Inc.
|
US
|
NASDAQ
|
|
URGN
|
UroGen Pharma Ltd.
|
US
|
NASDAQ
|